CG Oncology Inc. (CGON) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - CGON

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth254.70%

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-42.74%

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth2.62%

5Y CAGRN/A

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	254.7%	345.0%	176.6%	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	458.3%	144.2%	-52.1%	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	6.8%	-86.0%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	-98.2%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - CGON

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on CG Oncology Inc.

Compare with peers

Explore

Growth Analysis - CGON

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on CG Oncology Inc.

Compare with peers

Explore